Company profile for Sagent Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Most companies are built from the ground up. We decided to build SAGENT from the customer out. By focusing on customers’ needs, we’ve built in the attributes you told us matter to you most. Excellence is our standard, our motivation and our guide. We believe the measure of success is determined by you, our customers, and how well we are addressing your needs every day. SAGENT is a customer-focused company, delivering an ex...
Most companies are built from the ground up. We decided to build SAGENT from the customer out. By focusing on customers’ needs, we’ve built in the attributes you told us matter to you most. Excellence is our standard, our motivation and our guide. We believe the measure of success is determined by you, our customers, and how well we are addressing your needs every day. SAGENT is a customer-focused company, delivering an extensive portfolio of injectable products and fulfilling the evolving needs of the patients we serve through our unique network of global resources.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1901 N. Roselle Rd.Schaumburg, IL 60195
Telephone
Telephone
+1 847-908-1600
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/sagent-announces-launch-of-travoprost-ophthalmic-solution-usp-302555682.html

PR NEWSWIRE
15 Sep 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219196

FDA
09 Jul 2025

https://www.prnewswire.com/news-releases/sagent-and-qilu-announce-strategic-collaboration-to-expand-access-to-critical-injectables-in-us-302499316.html

PR NEWSWIRE
08 Jul 2025

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/kedaara-ta-associates-vie-for-minority-stake-in-sagent-pharma/articleshow/119553679.cms

ECONOMICTIMES
27 Mar 2025

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-19-2024-84054.pdf

FDA
19 Jun 2024

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-docetaxel-injection-usp-due-potential

FDA
29 May 2024

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty